The Role of HMGB1 in Invasive Candida albicans Infection

JiaoJiao Wang1, ChuanXin Wu2, YunYing Wang3

  • 1Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China.

Mycopathologia
|October 5, 2021
PubMed
Abstract

Insights

High mobility group box 1 (HMGB1) is elevated in invasive Candida albicans infections. Ethyl pyruvate (EP) reduces HMGB1, preventing fungal sepsis lethality and offering a potential therapeutic target.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pharmacology

Background:

  • High mobility group box 1 (HMGB1) is a known inflammatory mediator in bacterial sepsis.
  • The role of HMGB1 in fungal sepsis, specifically invasive Candida albicans infections, remains largely uncharacterized.
  • Ethyl pyruvate (EP) is an established inhibitor of HMGB1, demonstrating efficacy in bacterial sepsis models.

Purpose of the Study:

  • To investigate the role of HMGB1 in invasive Candida albicans infections.
  • To evaluate the therapeutic potential of Ethyl pyruvate (EP) in a model of fungal sepsis.

Main Methods:

  • Serum HMGB1 levels were measured in patients with C. albicans sepsis and controls.
  • Correlations between HMGB1 levels and clinical severity markers (PCT, CRP, BDG) were assessed.
  • Mice were infected with C. albicans and treated with EP, monitoring HMGB1, inflammatory cytokines (TNF-α, IL-6), tissue damage, and mortality.

Main Results:

  • Elevated serum HMGB1 levels were observed in patients with severe C. albicans sepsis, correlating with disease severity markers.
  • HMGB1 levels significantly increased in mice following C. albicans infection.
  • EP administration reduced HMGB1 levels, mitigated tissue damage, decreased pro-inflammatory cytokine release, and improved survival rates.

Conclusions:

  • HMGB1 is significantly upregulated during invasive C. albicans infections.
  • Ethyl pyruvate demonstrates a protective effect against C. albicans-induced lethality by inhibiting HMGB1.
  • HMGB1 presents a promising diagnostic and therapeutic target for invasive fungal infections.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...